|
Manreet Kanwar, MDCertificationsCo-Director, Division of Heart Failure and Pulmonary Hypertension; Director Mechanical Circulatory Support and Heart Transplantation University / Hospital AffiliationAllegheny General Hospital AboutDr. Kanwar is an advanced heart failure physician with expertise in the management of patients with cardiogenic shock, end stage heart failure and pulmonary hypertension. Dr. Kanwar has been on faculty at AGH since 2011 and serves as the Director for the Mechanical Circulatory Support and Cardiac Transplantation programs. A dedicated researcher, with over 75 peer reviewed, Dr. Kanwar has conducted several clinical trials as primary investigator in the field of heart failure and chronic thromboembolic pulmonary hypertension. Her research career is focused on the art of decision making using Artificial Intelligence and Machine Learning. She was elected to the Board of Directors for the International Society of Heart and Lung Transplantation and serves on the editorial board for the Journal of Heart and Lung Transplantation. Dr. Kanwar was named one of Pittsburgh Magazine's "Best Doctors" in 2019 and 2020.
|
Related Content
 Pecha Kuchavideo Pecha Kucha: Can Mechanical Preload Reduction benefit PatientsModerators: Navin Kapur, MD (Tufts Medical Center, USA) and Dan Burkhoff, MD, PhD (Cardiovascular Research Foundation,... |  video Panel Discussion: Targeting Heart Recovery in a Real‑World SettingModerator: Bobbi Bogaev Chapman, MD
Panelists:
Manreet Kanwar, MD (Allegheny General Hospital, USA)
Jane Wilcox, MD (Northwestern... |  video Manreet Kanwar, MD | Allegheny Health NetworkClinical Experience of a Real World Heart Recovery Program – Presented at A‑CURE 2022. |
Manuscripts & Publications
Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device supportLeft ventricular assist-device (LVAD) implantation is a life-saving therapy for patients with advanced heart failure (HF). With chronic unloading and circulatory support, LVAD-supported hearts often show significant reverse remodeling at the structural, cellular and molecular level. However, translation of these changes into meaningful cardiac recovery allowing LVAD explant is lagging.
|
|
Long-Term Survival on LVAD Support: Device Complications and End-Organ Dysfunction Limit Long-Term SuccessPreoperative variables can predict short term left ventricular assist device (LVAD) survival, but predictors of extended survival remain insufficiently characterized.
|
|
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction - A Randomized Clinical TrialWhat is the efficacy, safety, and tolerability of sacubitril/valsartan in patients with advanced chronic heart failure?
|